England is moving to ban the sale of high-caffeine energy drinks to anyone under the age of 16. The policy question is straightforward; the underlying science is worth examining carefully.
Under the new government measure, all retailers in England — including convenience stores and vending machines, not just major supermarkets — will be prohibited from selling energy drinks containing more than 150mg of caffeine per litre to under-16s. Several large chains, among them Tesco, Asda, Sainsbury’s, Aldi, Lidl, Morrisons, and Waitrose, have operated voluntary age-restriction schemes along similar lines for some time. The significance of the announcement lies in making that restriction mandatory and universal, closing the gap that previously allowed younger consumers to purchase these products from smaller retailers operating outside voluntary codes.
The rationale rests on a body of clinical evidence suggesting that caffeine affects children and adolescents more acutely than adults. For adults, excess caffeine is associated with disrupted sleep, anxiety, elevated nervousness, headaches, irritability, restlessness, an accelerated heart rate, and a dependency that can produce withdrawal symptoms. These effects are well-documented and broadly understood. What is less settled is the precise threshold at which caffeine becomes harmful for younger consumers.
Stephanie Green, a paediatric endocrinologist at Johns Hopkins Children’s Center, has noted that while 400 milligrams per day appears safe for most healthy adults, the equivalent safe limit for children remains unknown. The American Academy of Pediatrics takes a cautious position: it advises that those aged between 12 and 18 should consume no more than 100 milligrams per day and recommends they avoid energy drinks entirely. The reasoning centres on the vulnerability of developing brains and the proportionally smaller body mass of younger adolescents, both of which amplify caffeine’s physiological impact.
The health effects attributed to excess caffeine consumption in adolescents extend beyond the adult profile. Clinical literature points to sleep disruption, agitation, diarrhoea, dehydration, rapid breathing, elevated blood pressure, panic attacks, and, in more severe cases, seizures. There is also concern about behavioural and mental health consequences, including heightened aggression, anxiety, and depression — effects that carry particular weight given the already elevated rates of mental health difficulties among young people in Britain.
From a policy standpoint, the measure is a proportionate application of precautionary logic in an area where the science, while not exhaustive, points consistently in one direction. Voluntary retailer codes have demonstrated that age-gating is operationally feasible; legislating the requirement simply removes the competitive disadvantage faced by responsible retailers and eliminates the loopholes that undermine the voluntary framework. For policymakers and public health administrators, the more pressing question now is enforcement — ensuring that the ban functions in practice across the full retail landscape, rather than existing merely on paper.